Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.02B |
| 2 |
Microsoft
MSFT
|
+$337M |
| 3 |
Apple
AAPL
|
+$308M |
| 4 |
Meta Platforms (Facebook)
META
|
+$222M |
| 5 |
Amazon
AMZN
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Du Pont De Nemours E I
DD
|
+$886M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$515M |
| 3 |
BHI
Baker Hughes
BHI
|
+$212M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$165M |
| 5 |
VCA Inc.
WOOF
|
+$97.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.56% |
| 2 | Technology | 14.64% |
| 3 | Healthcare | 13.29% |
| 4 | Industrials | 10.84% |
| 5 | Consumer Discretionary | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4126
iShares National Muni Bond ETF
MUB
$49.2B
| $21K | ﹤0.01% |
19,175
-1,362
| -7% | -$151K |
2013 Q2
17 quarters
|
|
4127
Turtle Beach Corp
TBCH
$272M
| $21K | ﹤0.01% |
6,327
| – | – |
2013 Q2
17 quarters
|
|
4128
Aemetis
AMTX
$105M
| $20K | ﹤0.01% |
23,213
| – | – |
2014 Q3
12 quarters
|
|
4129
Cerenome
CNSY
$12.9M
| – | – |
0
| – | – |
2013 Q2
17 quarters
|
|
4130
iShares 1-3 Year Treasury Bond ETF
SHY
$26.9B
| $20K | ﹤0.01% |
23,865
-13,340
| -36% | -$1.13M |
2013 Q2
17 quarters
|
|
|
BIOC
4131
DELISTED
Biocept, Inc.
BIOC
| $20K | ﹤0.01% |
2
| – | – |
2017 Q1
2 quarters
|
|
|
BINI
4132
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
2016 Q2
5 quarters
|
|
|
CFRX
4133
DELISTED
ContraFect Corporation
CFRX
| $19K | ﹤0.01% |
22
| – | – |
2017 Q1
2 quarters
|
|
4134
Ocean Power Technologies
OPTT
$5.5M
| $18K | ﹤0.01% |
+24
| New | +$18.3K |
2017 Q3
0 quarters
|
|
4135
DELISTED
SunLink Health Systems
SSY
| $18K | ﹤0.01% |
11,695
| – | – |
2017 Q1
2 quarters
|
|
4136
Tenax Therapeutics
TENX
$50.9M
| $18K | ﹤0.01% |
2
| – | – |
2014 Q1
14 quarters
|
|
|
OCRX
4137
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $18K | ﹤0.01% |
15,883
| – | – |
2015 Q3
8 quarters
|
|
4138
Northern Trust Core Bond ETF
BNDC
$167M
| $17K | ﹤0.01% |
69,265
+38,587
| +126% | +$971K |
2017 Q2
1 quarter
|
|
4139
Microbot Medical
MBOT
$63.8M
| $17K | ﹤0.01% |
997
| – | – |
2017 Q1
2 quarters
|
|
4140
Protalix BioTherapeutics
PLX
$211M
| $17K | ﹤0.01% |
2,978
| – | – |
2013 Q2
17 quarters
|
|
4141
Retractable Technologies
RVP
$17.2M
| $17K | ﹤0.01% |
24,594
| – | – |
2014 Q1
14 quarters
|
|
4142
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.2B
| $17K | ﹤0.01% |
18,320
+4,397
| +32% | +$387K |
2017 Q2
1 quarter
|
|
4143
VistaGen Therapeutics
VTGN
$8.88M
| $17K | ﹤0.01% |
364
| – | – |
2017 Q1
2 quarters
|
|
4144
Solitario Resources
XPL
$48.8M
| $17K | ﹤0.01% |
24,532
| – | – |
2013 Q2
17 quarters
|
|
4145
DELISTED
Scorpius Holdings, Inc.
SCPX
| – | – |
0
| – | – |
2017 Q1
2 quarters
|
|
|
BBK
4146
DELISTED
Blackrock Municipal Bond Trust
BBK
| $17K | ﹤0.01% |
+110,000
| New | +$1.75M |
2017 Q3
0 quarters
|
|
4147
United States Antimony
UAMY
$427M
| $15K | ﹤0.01% |
50,843
-555
| -1% | -$183 |
2013 Q2
17 quarters
|
|
|
ESNC
4148
DELISTED
EnSync Inc
ESNC
| $15K | ﹤0.01% |
29,773
| – | – |
2014 Q1
14 quarters
|
|
4149
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $14K | ﹤0.01% |
+18,143
| New | +$1.45M |
2017 Q3
0 quarters
|
|
4150
SELLAS Life Sciences
SLS
$2.02B
| $14K | ﹤0.01% |
27
| – | – |
2016 Q4
3 quarters
|
|
Similar funds
Northern Trust's Q3 2017 Portfolio in Review
As of Q3 2017, Northern Trust held 4,364 positions worth $384B, up 7.3% from $358B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 4.5%. Northern Trust opened 89 new positions and exited 107, leaving the 4,364-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- Northern Trust's largest Q3 2017 buy was Baker Hughes: 5,053,073 shares worth $185M.
- Northern Trust added most to DuPont de Nemours in Q3 2017, an estimated $1.02B increase.
- Northern Trust's biggest Q3 2017 reduction was Northern Trust STOXX Global Broad Infrastructure ETF, cutting an estimated $73.5M.
- Northern Trust fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $886M.
- Northern Trust's ten largest holdings make up 14% of its $384B portfolio in Q3 2017.
- Northern Trust opened 89 new positions and closed 107 in Q3 2017.
- Northern Trust's portfolio value rose 7.3% quarter-over-quarter to $384B.
Based on Northern Trust's 13F filing for Q3 2017, filed 13 Nov 2017.